lifespin supports the startup scene at Harvard University in the United States
The company, founded in 2017 in the BioPark, is one of the so-called "deep data companies", i.e. an interdisciplinary team of today 17 employees combining diagnostic and bioanalytical methods with software solutions, including the use of artificial intelligence (AI). With the help of the most modern analyzes based on nuclear magnetic resonance technology, a database of metabolic profiles of more than 130,000 patients has already been built up, which already enables the analysis of more than a billion metabolic interactions. The biotech company is expecting the first officially approved test for multiple sclerosis as early as next year. More tests for other neurological and cancer-related diseases are to follow.
"lifespin's proprietary metabolite analysis platform will transform the way clinical chemistry is performed and advance personalized medicine," said Dr. Felix Wieland, elected member of the National Academy of Sciences Leopoldina, senior professor of biochemistry at Heidelberg University, lifespin board member and honorary member of the Charité. In order to drive development forward and to prepare the company for the next phase of international growth, the Regensburg-based company has become a founding member of the Wyss Diagnostics Accelerator Program at the Wyss Institute in Harvard.
As the first program of its kind within Harvard's biomedical system, the accelerator is intended to develop new diagnostic solutions and thus in particular to involve patients with disease risk factors that today simply cannot be assessed precisely and in good time. The method supported by AI is also suitable for monitoring the efficacy of new therapies with the necessary precision in clinical studies.
"We are very honored to have been selected and invited as one of the first members of the Accelerator," said Dr. Ali Tinazli, CEO of lifespin. " Cooperation with the world-class talents of the Wyss Institute and other IPP members also strengthens our location in Regensburg," said Tinazli. Lifespin is already working with the Regensburg universities and companies in the Regensburg Bioregion Cluster and welcomes the AI initiative " AIR-Artificial Intelligence Regensburg". Its aim is to network stakeholders from industry, science and city administration at the location and thus to improve the transfer of knowledge in the field of artificial intelligence in the long term.
